Angiodynamics, Inc. (ANGO) Beats Q4 EPS View by 1c; Guides Fy13
Tweet Send to a FriendGet Alerts ANGO Hot Sheet
Trade ANGO Now!
Angiodynamics, Inc. (NASDAQ: ANGO) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $57.7 million versus the consensus estimate of $52.97 million.
Sees FY2013 EPS of $0.49-$0.51, versus the consensus of $0.48. Angiodynamics, Inc. sees FY2013 revenue of $360-$363 million, versus the consensus of $356.7 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY2013 EPS of $0.49-$0.51, versus the consensus of $0.48. Angiodynamics, Inc. sees FY2013 revenue of $360-$363 million, versus the consensus of $356.7 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
- Semtech Corp (SMTC) Reports In-Line Q1 EPS, Offers Q2 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
